These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 19649919)
1. Influenza--the case for combination therapy. Krystal MR; Meanwell NA Curr Opin Investig Drugs; 2009 Aug; 10(8):746-9. PubMed ID: 19649919 [No Abstract] [Full Text] [Related]
2. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). Uyeki T N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564 [No Abstract] [Full Text] [Related]
3. Antiviral resistance in influenza viruses--implications for management and pandemic response. Hayden FG N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389 [No Abstract] [Full Text] [Related]
4. Use of neuraminidase inhibitors to combat pandemic influenza. Democratis J; Pareek M; Stephenson I J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904 [TBL] [Abstract][Full Text] [Related]
5. Global transmission of oseltamivir-resistant influenza. Moscona A N Engl J Med; 2009 Mar; 360(10):953-6. PubMed ID: 19258250 [No Abstract] [Full Text] [Related]
6. Oseltamivir resistance: what does it mean clinically? Baum SG Clin Infect Dis; 2009 Dec; 49(12):1836-7. PubMed ID: 19911972 [No Abstract] [Full Text] [Related]
7. Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus. van der Vries E; Stelma FF; Boucher CA N Engl J Med; 2010 Sep; 363(14):1381-2. PubMed ID: 20879894 [No Abstract] [Full Text] [Related]
8. Neuraminidase inhibitors and their role in avian and pandemic influenza. Crusat M; de Jong MD Antivir Ther; 2007; 12(4 Pt B):593-602. PubMed ID: 17944267 [TBL] [Abstract][Full Text] [Related]
9. Drug resistance. A 'wimpy' flu strain mysteriously turns scary. Enserink M Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605 [No Abstract] [Full Text] [Related]
12. Apropos "vaccines in a hurry". Arya SC; Agarwal N Vaccine; 2009 Aug; 27(36):4875. PubMed ID: 19560429 [No Abstract] [Full Text] [Related]
13. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus. Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442 [TBL] [Abstract][Full Text] [Related]
14. Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Rungrotmongkol T; Intharathep P; Malaisree M; Nunthaboot N; Kaiyawet N; Sompornpisut P; Payungporn S; Poovorawan Y; Hannongbua S Biochem Biophys Res Commun; 2009 Jul; 385(3):390-4. PubMed ID: 19463784 [TBL] [Abstract][Full Text] [Related]
15. The truth about Tamiflu? Neuraminidase inhibitors in pandemic A/H1N1 flu. Weber JT; Nicoll A; Bridges CB; Ciancio BC BMJ; 2010 Jan; 340():c130. PubMed ID: 20071425 [No Abstract] [Full Text] [Related]
16. Antiviral management of seasonal and pandemic influenza. Hayden FG; Pavia AT J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384 [TBL] [Abstract][Full Text] [Related]
17. [The new pandemic influenza A/H1N1. Antiviral agents for the initial stage--vaccine reduces the effects in the long run]. Uhnoo I; Bergquist C Lakartidningen; 2009 Jul 8-21; 106(28-29):1814-9. PubMed ID: 19685621 [No Abstract] [Full Text] [Related]
18. [Neuraminidase inhibitors in prophylaxis and treatment of influenza]. Nitsch-Osuch A; Brydak LB; Wardyn AK Pol Merkur Lekarski; 2008 Jul; 25(145):67-73. PubMed ID: 18839619 [TBL] [Abstract][Full Text] [Related]
19. Implications of antiviral resistance of influenza viruses. Monto AS Clin Infect Dis; 2009 Feb; 48(4):397-9. PubMed ID: 19586376 [No Abstract] [Full Text] [Related]